Literature DB >> 17991775

Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Markus Feuerer1, Wenyu Jiang, Phillip D Holler, Ansuman Satpathy, Christopher Campbell, Molly Bogue, Diane Mathis, Christophe Benoist.   

Abstract

FoxP3(+)CD4(+) regulatory T cells (Tregs) play a key role in the maintenance of peripheral self-tolerance, and it has been suggested that diabetes-susceptible nonobese diabetic (NOD) mice are defective in the generation and numbers of Tregs. We found thymic selection of Tregs to be under genetic control. Fetal thymic organ cultures on the NOD background required 3- to 10-fold more antigen than corresponding cultures on the B6 background for optimal induction of Tregs, but once the threshold for induction was reached the NOD background yielded close to 10-fold more Tregs. This increased selection of Tregs was also found in nontransgenic NOD mice in fetal through adult stages. This trait did not map to the MHC, idd3, or the chromosome 3 (Chr3) regions that control clonal deletion, but mainly to two regions on Chr1 and Chr11. Thus, NOD mice do not have a global defect in the generation or maintenance of Tregs; if anything, they show the opposite.

Entities:  

Mesh:

Year:  2007        PMID: 17991775      PMCID: PMC2084317          DOI: 10.1073/pnas.0708899104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor.

Authors:  Julien C Marie; Denny Liggitt; Alexander Y Rudensky
Journal:  Immunity       Date:  2006-09       Impact factor: 31.745

2.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity.

Authors:  Jun Yamanouchi; Dan Rainbow; Pau Serra; Sarah Howlett; Kara Hunter; Valerie E S Garner; Andrea Gonzalez-Munoz; Jan Clark; Riitta Veijola; Rose Cubbon; Show-Ling Chen; Raymond Rosa; Anne Marie Cumiskey; David V Serreze; Simon Gregory; Jane Rogers; Paul A Lyons; Barry Healy; Luc J Smink; John A Todd; Laurence B Peterson; Linda S Wicker; Pere Santamaria
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

3.  Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

Authors:  Pascale Alard; Jean N Manirarora; Sarah A Parnell; Jason L Hudkins; Sherry L Clark; Michele M Kosiewicz
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

4.  Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus.

Authors:  Roberto Bonasio; M Lucila Scimone; Patrick Schaerli; Nir Grabie; Andrew H Lichtman; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

Review 5.  Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.

Authors:  Shimon Sakaguchi; Masahiro Ono; Ruka Setoguchi; Haruhiko Yagi; Shohei Hori; Zoltan Fehervari; Jun Shimizu; Takeshi Takahashi; Takashi Nomura
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage.

Authors:  Julie Cabarrocas; Cécile Cassan; Fay Magnusson; Eliane Piaggio; Lennart Mars; Jens Derbinski; Bruno Kyewski; David-Alexandre Gross; Benoit L Salomon; Khashayarsha Khazaie; Abdelhadi Saoudi; Roland S Liblau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-18       Impact factor: 11.205

7.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

Review 8.  FOXP3: of mice and men.

Authors:  Steven F Ziegler
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

9.  Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.

Authors:  Zhibin Chen; Ann E Herman; Michael Matos; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-11-21       Impact factor: 14.307

10.  Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

Authors:  Kristin V Tarbell; Lucine Petit; Xiaopan Zuo; Priscilla Toy; Xunrong Luo; Amina Mqadmi; Hua Yang; Manikkam Suthanthiran; Svetlana Mojsov; Ralph M Steinman
Journal:  J Exp Med       Date:  2007-01-08       Impact factor: 14.307

View more
  38 in total

Review 1.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

2.  The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors.

Authors:  Anna Morena D'Alise; Vincent Auyeung; Markus Feuerer; Junko Nishio; Jason Fontenot; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

3.  Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells.

Authors:  Cristina Ferreira; Yogesh Singh; Anna L Furmanski; F Susan Wong; Oliver A Garden; Julian Dyson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

4.  Differentiation of regulatory Foxp3+ T cells in the thymic cortex.

Authors:  Adrian Liston; Katherine M Nutsch; Andrew G Farr; Jennifer M Lund; Jeffery P Rasmussen; Pandelakis A Koni; Alexander Y Rudensky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

Review 5.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

6.  Regulatory T cell differentiation of thymocytes does not require a dedicated antigen-presenting cell but is under T cell-intrinsic developmental control.

Authors:  Gerald Wirnsberger; Florian Mair; Ludger Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-10       Impact factor: 11.205

Review 7.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

8.  Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice.

Authors:  Kevin S Goudy; Bo Wang; Roland Tisch
Journal:  Clin Immunol       Date:  2008-10       Impact factor: 3.969

9.  Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints.

Authors:  Junko Nishio; Markus Feuerer; Jamie Wong; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

10.  Intraclonal competition limits the fate determination of regulatory T cells in the thymus.

Authors:  Jhoanne L Bautista; Chan-Wang J Lio; Stephanie K Lathrop; Katherine Forbush; Yuqiong Liang; Jingqin Luo; Alexander Y Rudensky; Chyi-Song Hsieh
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.